EnBio Holdings, Inc

EnBio Holdings, Inc

6092.T
EnBio Holdings, IncJP flagTokyo Stock Exchange
718.00
JPY
+6.00
- -
5.83BMarket Cap

Total Valuation

EnBio Holdings, Inc carries a market capitalization of 5.83B, placing it among publicly traded companies globally. Its enterprise value stands at 9.62B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap5.83B
Enterprise Value9.62B

Share Statistics

EnBio Holdings, Inc currently has 8.14M shares outstanding.

Shares Outstanding8.14M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

EnBio Holdings, Inc trades at a trailing price-to-earnings ratio of 6.37. The price-to-sales ratio is 0.47, and the price-to-book ratio stands at 0.74.

PE Ratio6.37
PS Ratio0.47
PB Ratio0.74
P/TBV Ratio0.56
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, EnBio Holdings, Inc trades at an EV/EBITDA multiple of 11.81 and an EV/FCF ratio of 120.96. The EV/Sales ratio of 1.01 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 11.81 provides insight into valuation relative to core operating earnings.

EV / Sales1.01
EV / EBITDA11.81
EV / EBIT11.81
EV / FCF120.96

Financial Position

EnBio Holdings, Inc maintains a current ratio of 1.99, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 100.33, indicating elevated leverage, while an interest coverage ratio of 7.11 demonstrates adequate ability to service its debt obligations.

Current Ratio1.99
Quick Ratio0.87
Debt / Equity100.33
Debt / EBITDA10.57
Interest Coverage7.11

Financial Efficiency

EnBio Holdings, Inc posts a return on equity of 12.89 and a return on invested capital of 3.38.

Return on Equity (ROE)12.89
Return on Assets (ROA)3.87
Return on Invested Capital (ROIC)3.38
Return on Capital Employed (ROCE)5.28
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover2.26

Taxes

Over the trailing twelve months, EnBio Holdings, Inc has paid 326.25M in income taxes, reflecting an effective tax rate of 30.61.

Income Tax326.25M
Effective Tax Rate30.61

Stock Price Statistics

EnBio Holdings, Inc's stock has gained approximately 14.33121% over the past 52 weeks. The 50-day moving average sits at 769.24, while the 200-day moving average is 682.27.

Beta (5Y)N/A
52-Week Price Change14.33121%
50-Day Moving Average769.24
200-Day Moving Average682.27
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, EnBio Holdings, Inc generated 9.58B in revenue and converted that into 708.76M in net income, yielding earnings per share of 98.70. EBITDA reached 815.16M, while operating income came in at 815.16M.

Revenue9.58B
Gross Profit2.48B
Operating Income815.16M
Pretax Income1.07B
Net Income708.76M
EBITDA815.16M
EBIT815.16M
Earnings Per Share (EPS)98.70

Balance Sheet

EnBio Holdings, Inc holds 3.60B in cash and equivalents against 8.62B in total debt, resulting in a net debt position of 5.02B. Total book value stands at 6.09B, with working capital of 4.10B providing operational flexibility.

Cash & Cash Equivalents3.60B
Total Debt8.62B
Net Debt5.02B
Equity (Book Value)6.09B
Book Value Per Share812.18
Working Capital4.10B

Margins

EnBio Holdings, Inc operates with a gross margin of 25.94, reflecting its pricing power and cost economics. The operating margin of 8.51 and net profit margin of 7.40 provide insight into operational efficiency.

Gross Margin25.94
Operating Margin8.51
Pretax Margin11.13
Profit Margin7.40
EBITDA Margin8.51

Scores

EnBio Holdings, Inc posts an Altman Z-Score of 1.44, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score1.44